Insiderkauf

Relmada Therapeutics

RLMD

Insidertransaktionen und Aktienkurs 2024-2026

Alle Insidertrades bei Relmada Therapeutics

RSS abonnieren
Datum Typ Insider Position Ø-Preis Volumen
15.12.2025 Kauf Shenouda, Maged Chief Financial Officer 4,1 $ 48.060 $
15.12.2025 Kauf Traversa, Sergio Chief Executive Officer 4,1 $ 113.300 $
5.11.2025 Kauf Kelly, Paul Edward Chief Operating Officer 2,2 $ 198.000 $
5.11.2025 Kauf Shenouda, Maged Chief Financial Officer 2,2 $ 1.100.000 $
5.11.2025 Kauf Traversa, Sergio Chief Executive Officer 2,2 $ 599.500 $
5.11.2025 Kauf Ence, Chuck CAO and COO 2,2 $ 299.200 $
28.8.2025 Kauf Traversa, Sergio Chief Executive Officer 0,7 $ 41.422 $
27.8.2025 Kauf Traversa, Sergio Chief Executive Officer 0,7 $ 86.735 $
26.8.2025 Kauf Traversa, Sergio Chief Executive Officer 0,6 $ 49.938 $
20.5.2025 Kauf Traversa, Sergio Chief Executive Officer 0,6 $ 82.246 $
20.5.2025 Kauf Shenouda, Maged Chief Financial Officer 0,5 $ 31.422 $
19.5.2025 Kauf Traversa, Sergio Chief Executive Officer 0,5 $ 14.994 $
19.5.2025 Kauf Shenouda, Maged Chief Financial Officer 0,5 $ 43.686 $
16.5.2025 Kauf Traversa, Sergio Chief Executive Officer 0,4 $ 77.472 $
16.5.2025 Kauf Ence, Chuck CA and CO 0,5 $ 103.330 $
16.5.2025 Kauf Shenouda, Maged Chief Financial Officer 0,4 $ 22.100 $
16.5.2025 Kauf Kelly, Paul Edward Chief Operating Officer 0,4 $ 86.060 $
11.9.2024 Kauf Shenouda, Maged Chief Financial Officer 3,0 $ 71.154 $
11.9.2024 Kauf Traversa, Sergio Chief Executive Officer 3,0 $ 153.707 $
10.9.2024 Kauf Shenouda, Maged Chief Financial Officer 2,7 $ 57.652 $
10.9.2024 Kauf Traversa, Sergio Chief Executive Officer 2,8 $ 90.789 $
9.9.2024 Kauf Kelly, Paul Edward Aufsichtsrat 2,6 $ 64.750 $
9.9.2024 Kauf Shenouda, Maged Chief Financial Officer 2,6 $ 20.895 $
9.9.2024 Kauf Casamento, Charles J. Aufsichtsrat 2,6 $ 33.280 $
9.9.2024 Kauf Traversa, Sergio Chief Executive Officer 2,7 $ 150.619 $
Rows per page:
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)